
-- Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both the full ITT population (p
On 6ix: 6ix.com/news/newamsterdam-pharma-announces-positive-topline-alzheimers-disease-data-broadway

-- Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both the full ITT population (p
NewAmsterdam Pharma Company N.V. on 6ix
Follow NewAmsterdam Pharma into a list and get an email when it puts out news.
Follow NewAmsterdam Pharma